Finepoint Capital LP 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
Finepoint Capital LP disclosed 23 US equity positions worth $592.8m in its Q1 2025 13F filing. The largest position was QXO at 55.9% of the reported book, followed by 8L8C and SWTXUSD. Against the Q4 2024 filing, it opened 0 new positions, added to 0 and reduced 16 among the top 23 holdings.
What did Finepoint Capital LP own in Q1 2025? Top 23 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | QXO QXO INC | Industrials | 55.9% | $331.3m | 24,468,160 | -2% | reduced |
| 2 | 8L8C Liberty Broadband Corp | 7.6% | $45.0m | 529,240 | -74% | reduced | |
| 3 | SWTXUSD SPRINGWORKS THERAPEUTICS INC | 5.4% | $32.2m | 728,602 | -3% | reduced | |
| 4 | LIBERTY MEDIA CORP DEL | 5.0% | $29.5m | 432,895 | -47% | reduced | |
| 5 | ASND ASCENDIS PHARMA A/S | Healthcare | 4.7% | $28.0m | 179,872 | -3% | reduced |
| 6 | RVMD REVOLUTION MEDICINES INC | Healthcare | 4.1% | $24.4m | 691,260 | -3% | reduced |
| 7 | MLTX MoonLake Immunotherapeutics | Healthcare | 2.9% | $17.0m | 435,785 | -3% | reduced |
| 8 | LKFT GALAPAGOS NV | Healthcare | 2.8% | $16.5m | 656,587 | -3% | reduced |
| 9 | CYTK CYTOKINETICS INC | Healthcare | 2.1% | $12.5m | 309,948 | -3% | reduced |
| 10 | RNAGBP AVIDITY BIOSCIENCES INC | 1.9% | $11.2m | 380,700 | -3% | reduced | |
| 11 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 1.7% | $10.1m | 157,555 | -3% | reduced |
| 12 | PROTHENA CORP PLC | 1.3% | $7.9m | 640,071 | -3% | reduced | |
| 13 | XNCR XENCOR INC | Healthcare | 1.2% | $6.8m | 642,200 | -3% | reduced |
| 14 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 1.0% | $5.9m | 1,081,954 | -3% | reduced |
| 15 | RLAY RELAY THERAPEUTICS INC | Healthcare | 0.9% | $5.5m | 2,117,646 | -3% | reduced |
| 16 | ARVN ARVINAS INC | Healthcare | 0.8% | $4.9m | 694,028 | -3% | reduced |
| 17 | SLDB SOLID BIOSCIENCES INC | Healthcare | 0.6% | $3.6m | 961,251 | 0% | held |
| 18 | ALEANNA INC | 0.0% | $208.7k | 27,717 | 0% | held | |
| 19 | ALEANNA INC | 0.0% | $122.5k | 490,000 | 0% | held | |
| 20 | Marblegate Acquisition Corp | 0.0% | $117.6k | 735,000 | 0% | held | |
| 21 | MONEYHERO LIMITED | 0.0% | $32.8k | 895,000 | 0% | held | |
| 22 | LAKESHORE BIOPHARMA CO LTD | 0.0% | $20.2k | 489,999 | 0% | held | |
| 23 | CALIDI BIOTHERAPEUTICS INC | 0.0% | $7.1k | 12,499 | -0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.